Long-acting technologies
31 articles
LAT CAB Brochure
Learn about LAT CAB, Longevity project and meet the LAT CAB community experts. More
Community Call to Action on Equitable Access to Long-Acting Therapies
The growing pipeline for LAT and their potential to accelerate various disease elimination goals warrants global community mobilization to ensure equitable access to these therapies. More
Prospects for Long-Acting Treatments for Hepatitis C
Long-acting parenteral formulations of HCV treatment may allow people living with hepatitis C virus infection to be diagnosed and cured in a single encounter. More
Long-Acting Therapies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria
Treatment Action Group releases a trials tracker providing a compilation of ongoing clinical trials on long-acting treatments for HCV, malaria, and opioid use and overdose prevention. More
Preferences of Patients and Providers in High-Burden Malaria Settings for Long-Acting Malaria Chemoprevention
A survey of Kenyan and Zambian patient end-users, prescribers, and policymakers evaluates the acceptance of and potential concerns about long-acting formulations of malaria chemoprevention. More
